We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 123

Federal court affirms standing for innovative drug manufacturer

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 23 2014

What rights do innovative drug manufacturers have in situations where generics challenge certain Health Canada decisions but do not name the

Apotex v. Sanofi; interlocutory motion re: affidavits of documents; clopidogrel

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 12 2010

Both parties brought motions for further and better affidavits of documents

PMPRB decisions and cases the year 2009 in review

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 3 2010

During 2009, a number of key decisions issued from panels of the Patented Medicine Prices Review Board (PMPRB) and the courts on issues relating to Canada's federal system of price control

Sanofi-Aventis v. ApotexNovopharmRiva, interlocutory motion to consolidate actions

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 20 2010

Sanofi brought a motion to consolidate three actions pertaining to damages pursuant to section 8 of the NOC Regulations

Pfizer v Ranbaxy; 55.2 proceeding; October 5, 2007 - atorvastatin

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 25 2007

The trial judge granted prohibition in respect of one patent claiming a novel crystalline form of atorvastatin (the "crystalline form patent") and denied prohibition in respect of another patent claiming a novel process for making atorvastatin (the "process patent"

Bayer v. Canada

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 28 2009

The Court of Appeal dismissed Bayer’s appeal, thus affirming the refusal to list the patent on the Patent Register

AstraZeneca v. Novopharm, appeal of decision to strike Statement of Claim

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes to strike AstraZeneca's Statement of Claim

Lundbeck v. Ratiopharm and Cobalt

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 28 2009

The Court of Appeal upheld the decision of the applications judge who struck the applications for judicial review

Lundbeck v. Cobalt and Ratiopharm

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 19 2009

Lundbeck brought a judicial review of the Minister's decision to accept the generic companies' ANDSs for their brand of memantine

AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing